VentriPoint Diagnostics Ltd.
VPTDF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $21 | $29 | $16 | $28 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $2 | $2 | $2 | $1 |
| Enterprise Value | $23 | $30 | $17 | $29 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | -100% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | 100% | – | 100% |
| EBITDA | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | -1,170.5% | – | -1,826.9% |
| Net Income | -$1 | -$1 | -$1 | -$1 |
| % Margin | – | -1,345.7% | – | -1,939.4% |
| EPS Diluted | -0.008 | -0.006 | -0.007 | -0.008 |
| % Growth | -33.9% | 10.6% | 17.5% | – |
| Operating Cash Flow | -$1 | -$0 | -$1 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$0 | -$1 | -$1 |